...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2)
【24h】

Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2)

机译:芳基哌嗪新模型的合成与构效关系5.药效基团对5-HT(1a)/ alpha(1)-肾上腺素能受体亲和力的物理化学影响的研究:合成具有5-HT(1a)/ d(2)混合的新衍生物

获取原文
获取原文并翻译 | 示例
           

摘要

In this paper we have designed and synthesized a test series of 32 amide arylpiperazine derivatives VI in order to gain insight into the physicochemical influence of the pharmacophores of 5-HT(1A) and alpha(1)-adrenergic receptors. The training set was designed applying a fractional factorial design using six physicochemical descriptors. The amide moiety is a bicyclohydantoin or a diketopiperazine (X = -(CH(2))(3)-, -(CH(2))(4)-; m = 0, 1), the spacer length is 3 or 4 methylene units, which are the optimum values for both receptors, and the aromatic substituent R occupies the ortho- or meta-position and has been selected from a database of 387 substituents using the EDISFAR program. The 5-HT(1A) and alpha(1)-adrenergic receptor binding affinities of synthesized compounds VI (1-32) have been determined. This data set has been used to derive classical quantitative structure-activity relationships (QSAR) and neural networks models for both receptors (following paper). A comparison of these models gives information for the design of the new ligand EF-7412 (46) (5-HT(1A): K(i) = 27 nM; alpha(1): K(i) > 1000 nM). This derivative displays affinity for the dopamine D(2) receptor (K(i) = 22 nM) and is selective versus all other receptors examined (5-HT(2A), 5-HT(3), 5-HT(4) and Bz; K(i) > 1000 nM). EF-7412 (46) acts as an antagonist in vivo in pre- and postsynaptic 5-HT(1A) receptor sites and as an antagonist in the dopamine D(2) receptor. Thus, EF-7412 (46) is a derivative with mixed 5-HT(1A)/D(2) antagonist properties and this derivative could be useful as a pharmacological tool.
机译:在本文中,我们设计并合成了32种酰胺芳基哌嗪衍生物VI的测试系列,以便深入了解5-HT(1A)和α(1)-肾上腺素能受体的药效基团的理化影响。使用分数理化设计(使用六个物理化学描述符)设计训练集。酰胺部分是双环乙内酰脲或二酮哌嗪(X =-(CH(2))(3)-,-(CH(2))(4)-; m = 0,1),间隔子长度为3或4亚甲基单元是两个受体的最佳值,芳族取代基R占据邻位或间位,并且已使用EDISFAR程序从387个取代基的数据库中进行选择。已确定了合成化合物VI(1-32)的5-HT(1A)和α(1)-肾上腺素受体结合亲和力。该数据集已被用于推导两种受体的经典定量构效关系(QSAR)和神经网络模型(以下论文)。这些模型的比较为新配体EF-7412(46)的设计提供了信息(5-HT(1A):K(i)= 27 nM; alpha(1):K(i)> 1000 nM)。此衍生物显示出对多巴胺D(2)受体的亲和力(K(i)= 22 nM),并且相对于所有其他受检受体具有选择性(5-HT(2A),5-HT(3),5-HT(4)和Bz; K(i)> 1000 nM)。 EF-7412(46)在体内突触前和突触后5-HT(1A)受体中充当拮抗剂,并在多巴胺D(2)受体中充当拮抗剂。因此,EF-7412(46)是具有混合的5-HT(1A)/ D(2)拮抗剂特性的衍生物,该衍生物可用作药理学工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号